FibroGen Stock Forecast

FGEN's stock price has decreased by -87.63% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for FibroGen stock has a target of 10, which predicts an increase of 2,954.37% from the current stock price of 0.33.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$10	$10	$10
Change	+2954.4%	+2954.4%	+2954.4%	+2954.4%

Analyst Ratings

According to 1 stock analyst, the rating for FibroGen is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	0	0	0	0	1	1
Buy	0	0	0	0	0	0
Hold	4	4	4	4	0	0
Sell	1	1	1	1	0	0
Strong Sell	1	1	1	1	0	0
Total	6	6	6	6	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+2,954.37%	Mar 18, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+2,954.37%	Feb 20, 2025
Jason Gerberry B of A Securities	B of A Securities	Hold → Sell Downgrades $4 → $2	Hold → Sell	Downgrades	$4 → $2	+510.87%	Aug 8, 2023
Paul Choi Goldman Sachs	Goldman Sachs	Strong Sell Maintains $16 → $2	Strong Sell	Maintains	$16 → $2	+510.87%	Jun 27, 2023
Danielle Brill Raymond James	Raymond James	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Jun 27, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

169.47M

from 29.62M

472.13%

from 29.62M

Revenue Next Year

181.56M

from 169.47M

7.13%

from 169.47M

EPS This Year

-0.46

from -0.48

EPS Next Year

-0.39

from -0.46

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2028
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2028
Revenue	176.32M	235.31M	140.73M	46.80M	29.62M	169.47M	181.56M	275.81M
Revenue Growth	-31.28%	33.46%	-40.19%	-66.74%	-36.71%	472.13%	7.13%	51.91%
EPS	-2.11	-3.14	-3.14	-2.92	-0.48	-0.46	-0.39	-
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2028
High	196.7M	215.3M	283.9M
Avg	169.5M	181.6M	275.8M
Low	142.1M	148.0M	265.0M

Revenue Growth

Revenue Growth	2025	2026	2028
High	564.0%	27.0%	56.4%
Avg	472.1%	7.1%	51.9%
Low	379.7%	-12.7%	46.0%

EPS Forecast

EPS	2025	2026
High	-0.40	-0.21
Avg	-0.46	-0.39
Low	-0.52	-0.55

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.